Clik here to view.
Small Companies, Big Returns
The broader biotech indices are up more than 30 percent this year and have reached levels not seen since the peak of March 2000. Larger biotechs account for much of the index returns, as we have...
View ArticleClik here to view.
Harder, Better, Faster, Stronger: Takeaways from Partnering For Cures 2012
The chorus to Kanye West’s 2007 chart-topper Stronger can teach us volumes about speeding drug development. Harder: Drug development is challenging. It takes over 10 years and more than $1 billon to...
View ArticleClik here to view.
Anti-Biotech Activist Changes Sides: “I discovered science”
If you missed last week’s report from the Oxford Farming Conference, Mark Lynas, the British writer and environmentalist who once helped drive Europe’s movement against biotech crops, apologized for...
View ArticleWhat’s Behind the Rise in Executive Liability Insurance Prices?
What do gas, milk, bacon, electricity and now your Directors and Officers Liability Insurance coverage have in common? It may sound like the start of a bad joke but, in fact, they’re all goods or...
View ArticleAuto Injectors & Pen Injectors: Differentiating Products in Asia Pacific
Asia Pacific, with its mix of mature and emerging pharmaceutical markets and strong indigenous R&D capabilities, has no doubt already become a prominent driving force for the current and future...
View ArticleClik here to view.
2013 BIO International Convention Program Highlights
I’m thrilled to be attending the upcoming 2013 BIO International Convention that is coming to Chicago April 22-25. The educational sessions, networking, business forum, and exhibits are coming together...
View ArticleWord on the Street – Biotech Stocks Only Have Room to Go Up
The Opening Lunch Plenary at this year’s BIO CEO & Investor Conference was a lively discussion between portfolio managers and senior buy-side analysts looking to forecast the year ahead in biotech....
View ArticleDespite Low Funding, Biotech Productivity Remains High In 2013
At the 2013 BIO CEO & Investor Conference, John Milligan, President and COO of Gilead Sciences, spoke in a standing room only fireside chat with Joel Sendek, Managing Director of Stifel Nicolaus,...
View ArticleClik here to view.
Debunking Ag Biotech’s Top 5 Myths
On Reason.com, award-winning science correspondent Ronald Bailey takes on the Institute for Responsible Technology (IRT), an organization opposed to crop biotechnology. IRT published a list of reasons...
View ArticleClik here to view.
BIO Business Solutions at the 2013 BIO International Convention
Do you wish to save money for your company? Is your company a member of BIO or state and regional biotech associations? Would you like to be recognized as a preferred supplier? If you answered yes to...
View ArticleDiversity Critical to Building Rich Bioscience Centers
Whether producing natural gas from coal or creating lifesaving medicines, unique experiences are what often lead to great discoveries. The more diverse the backgrounds and interests of those working in...
View ArticleFinding Biotech in the Silicon Prairie
The Silicon Prairie is about more than technology companies and Internet start-ups. In fact, the biotech industry in Illinois employs nearly 80,000 people, according to a recent analysis by Battelle,...
View ArticleState of the Biotech Industry: Burrill’s Biotech 2013 Report
To open his Super Session at the 2013 BIO International Convention, G. Steven Burrill, CEO of Burrill & Company, injected some humor for the hundreds of attendees in the audience, saying after 45...
View ArticleBuild Credibility As You Build Your Business
Whether you are a first-time entrepreneur or a veteran company executive, the one aspect of growing a business and raising capital, or selling a product rarely discussed at seminars is the building of...
View ArticleClik here to view.
World Food Prize Honors Ag Biotech Pioneers
A trio of scientists specializing in agricultural biotechnology will receive the 2013 World Food Prize, Secretary of State John Kerry announced today. Mary-Dell Chilton, Robert T. Fraley and Marc Van...
View ArticleClik here to view.
Industry Growth Factor: Biologics
Last week, EvaluatePharma released their updated sales and R&D outlook for the drug industry in their report “World Preview 2013, Outlook to 2018”. Among the 37 pages of data, one central take home...
View ArticleClik here to view.
What’s Really Happening with the So-called ‘Blend Wall’? A Fuels America...
The public dialog surrounding the Renewable Fuel Standard is robust- and filled with misinformation. On July 11, Rep. Lee Terry and Rep. Bruce Braley held the third of a series of briefings, which...
View ArticleClik here to view.
Have Questions About GMOs? We Know How to Get the Answers.
The ag biotech community – companies, scientists, health experts, farmers, industry organizations – have come together launching a new initiative to provide accurate information and answer the toughest...
View ArticleClik here to view.
Biotech IPO Boom or Bubble? The Opening Plenary at the BIO Investor Forum
With 31 (and counting) life sciences companies having already placed IPOs on the market within the first 8 months of this year and many others lining up for S-1 filings, biotech is buzzing about a...
View ArticleClik here to view.
The New Road to IPO in the Age of the JOBS Act
Not surprisingly, sessions discussing the topic of IPOs at this year’s BIO Investor Forum, tend to fill the room. Furthermore, it should surprise no one that this year’s IPO discussions were upbeat....
View Article
